Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New gel injection shows promise for eye disease

NCT ID NCT02931175

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 19 times

Summary

This study tested a gel called ACTH gel, given as a shot under the skin, to see if it can help control non-infectious uveitis, a condition that causes swelling inside the eye. The trial included 28 people with active eye inflammation. Researchers looked at how safe the gel was and whether it improved eye symptoms like blurry vision from inflammation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UVEITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Metropolitan Eye Research and surgery Institute

    Waltham, Massachusetts, 02451, United States

  • Retina Centers Professional Corporation - RCPC

    Cleveland, Ohio, 44139, United States

  • Retina Consultants of Houston

    Bellaire, Texas, 77401, United States

  • Retina Vitreous Associates, Medical Group

    Los Angeles, California, 90017, United States

  • Stanford University

    Palo Alto, California, 94303, United States

  • TExas Retina Associates

    Dallas, Texas, 75231, United States

  • Texas Retina Assiciates

    Dallas, Texas, 75231, United States

Conditions

Explore the condition pages connected to this study.